The announcement also said all medical equipment, drugs and vaccines imported by the academy would be considered its property for the purpose of medicine and public health and will not be liable to any kind of legal execution.
On Thursday the academy invited the media to a press conference titled “Approaches to procure and import an alternative Covid-19 vaccine from Sinopharm”, which is held in association with the Public Health Ministry and the Food and Drug Administration (FDA), on Friday (May 28) at the academy office located on Chaengwatthana Road, Soi 7, Bangkok.
On Monday, FDA secretary-general Dr Paisan Dankhum said Bio Genetech Ltd, an importer of Sinopharm’s Covilo vaccine, had submitted complete documentation to register the vaccine for use in Thailand and expected approval to come soon.
A news source speculated that Thailand would import at least 1 million doses of Covilo as an alternative to the main Sinovac and AstraZeneca vaccines.
Published : May 27, 2021
By : THE NATION